|
Vivier
Pharma Inc. has designed a unique "drug delivery system"
called IntraDermal System - IDSTM!
The most important feature of their IntraDermal System
- IDSTM is its ability to increase drug flux across
the stratum corneum (the true skin) by diffusion and thereby changing
the ability of the drug to penetrate the intercellular space i.e.,
"depot / retention" effect in the layers of the skin (stratum
corneum, epidermis and dermis).
Why
is this "depot / retention effect" so important?
This
unique "depot / retention" effect in the layers of the skin
can improve a drug's or simply a moisturizer's efficiency while
significantly reducing its systemic absorption (into the bloodstream).
|
|
What
makes these products unique and superior to existing topical products?
Often, formulation development of
a topical product is based on maximizing the flux across the skin only
rather than optimizing drug delivery to the target site. The IntraDermal
System - IDSTM formulations
penetrate in a controlled manner in the layers of the skin.
Vivier has designed products in
their novel "drug delivery system" called IntraDermal
System - IDSTM to do even more! Their IntraDermal
System - IDSTM is designed to penetrate in a
controlled manner and to deposit an active ingredient into the skin of
the affected area and to moisturize the damaged area of the skin.
*Source - Vivier
Pharma Inc. brochure and website. |